184 related articles for article (PubMed ID: 18574002)
1. In vitro biliary clearance of angiotensin II receptor blockers and 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors in sandwich-cultured rat hepatocytes: comparison with in vivo biliary clearance.
Abe K; Bridges AS; Yue W; Brouwer KL
J Pharmacol Exp Ther; 2008 Sep; 326(3):983-90. PubMed ID: 18574002
[TBL] [Abstract][Full Text] [Related]
2. Use of sandwich-cultured human hepatocytes to predict biliary clearance of angiotensin II receptor blockers and HMG-CoA reductase inhibitors.
Abe K; Bridges AS; Brouwer KL
Drug Metab Dispos; 2009 Mar; 37(3):447-52. PubMed ID: 19074974
[TBL] [Abstract][Full Text] [Related]
3. An experimental approach to evaluate the impact of impaired transport function on hepatobiliary drug disposition using Mrp2-deficient TR- rat sandwich-cultured hepatocytes in combination with Bcrp knockdown.
Yang K; Pfeifer ND; Hardwick RN; Yue W; Stewart PW; Brouwer KL
Mol Pharm; 2014 Mar; 11(3):766-75. PubMed ID: 24410402
[TBL] [Abstract][Full Text] [Related]
4. In vivo biliary clearance should be predicted by intrinsic biliary clearance in sandwich-cultured hepatocytes.
Nakakariya M; Ono M; Amano N; Moriwaki T; Maeda K; Sugiyama Y
Drug Metab Dispos; 2012 Mar; 40(3):602-9. PubMed ID: 22190695
[TBL] [Abstract][Full Text] [Related]
5. Decreased hepatic breast cancer resistance protein expression and function in multidrug resistance-associated protein 2-deficient (TR⁻) rats.
Yue W; Lee JK; Abe K; Sugiyama Y; Brouwer KL
Drug Metab Dispos; 2011 Mar; 39(3):441-7. PubMed ID: 21106720
[TBL] [Abstract][Full Text] [Related]
6. Use of mechanistic modeling to assess interindividual variability and interspecies differences in active uptake in human and rat hepatocytes.
Ménochet K; Kenworthy KE; Houston JB; Galetin A
Drug Metab Dispos; 2012 Sep; 40(9):1744-56. PubMed ID: 22665271
[TBL] [Abstract][Full Text] [Related]
7. Successful Prediction of In Vivo Hepatobiliary Clearances and Hepatic Concentrations of Rosuvastatin Using Sandwich-Cultured Rat Hepatocytes, Transporter-Expressing Cell Lines, and Quantitative Proteomics.
Ishida K; Ullah M; Tóth B; Juhasz V; Unadkat JD
Drug Metab Dispos; 2018 Jan; 46(1):66-74. PubMed ID: 29084782
[TBL] [Abstract][Full Text] [Related]
8. Hepatic basolateral efflux contributes significantly to rosuvastatin disposition II: characterization of hepatic elimination by basolateral, biliary, and metabolic clearance pathways in rat isolated perfused liver.
Pfeifer ND; Bridges AS; Ferslew BC; Hardwick RN; Brouwer KL
J Pharmacol Exp Ther; 2013 Dec; 347(3):737-45. PubMed ID: 24080682
[TBL] [Abstract][Full Text] [Related]
9. Effect of plasma protein binding on in vitro-in vivo correlation of biliary excretion of drugs evaluated by sandwich-cultured rat hepatocytes.
Fukuda H; Ohashi R; Tsuda-Tsukimoto M; Tamai I
Drug Metab Dispos; 2008 Jul; 36(7):1275-82. PubMed ID: 18388177
[TBL] [Abstract][Full Text] [Related]
10. Knocking down breast cancer resistance protein (Bcrp) by adenoviral vector-mediated RNA interference (RNAi) in sandwich-cultured rat hepatocytes: a novel tool to assess the contribution of Bcrp to drug biliary excretion.
Yue W; Abe K; Brouwer KL
Mol Pharm; 2009; 6(1):134-43. PubMed ID: 19105722
[TBL] [Abstract][Full Text] [Related]
11. Biliary efflux transporters involved in the clearance of rosuvastatin in sandwich culture of primary rat hepatocytes.
Jemnitz K; Veres Z; Tugyi R; Vereczkey L
Toxicol In Vitro; 2010 Mar; 24(2):605-10. PubMed ID: 19853032
[TBL] [Abstract][Full Text] [Related]
12. Effects of HMG-CoA reductase inhibitors on the pharmacokinetics of losartan and its main metabolite EXP-3174 in rats: possible role of CYP3A4 and P-gp inhibition by HMG-CoA reductase inhibitors.
Yang SH; Choi JS; Choi DH
Pharmacology; 2011; 88(1-2):1-9. PubMed ID: 21709429
[TBL] [Abstract][Full Text] [Related]
13. Hepatic basolateral efflux contributes significantly to rosuvastatin disposition I: characterization of basolateral versus biliary clearance using a novel protocol in sandwich-cultured hepatocytes.
Pfeifer ND; Yang K; Brouwer KL
J Pharmacol Exp Ther; 2013 Dec; 347(3):727-36. PubMed ID: 24023367
[TBL] [Abstract][Full Text] [Related]
14. P-glycoprotein-mediated in vitro biliary excretion in sandwich-cultured rat hepatocytes.
Annaert PP; Turncliff RZ; Booth CL; Thakker DR; Brouwer KL
Drug Metab Dispos; 2001 Oct; 29(10):1277-83. PubMed ID: 11560870
[TBL] [Abstract][Full Text] [Related]
15. Prediction of the hepatic and renal clearance of transporter substrates in rats using in vitro uptake experiments.
Watanabe T; Maeda K; Kondo T; Nakayama H; Horita S; Kusuhara H; Sugiyama Y
Drug Metab Dispos; 2009 Jul; 37(7):1471-9. PubMed ID: 19364828
[TBL] [Abstract][Full Text] [Related]
16. Effect of albumin on the biliary clearance of compounds in sandwich-cultured rat hepatocytes.
Wolf KK; Brouwer KR; Pollack GM; Brouwer KL
Drug Metab Dispos; 2008 Oct; 36(10):2086-92. PubMed ID: 18653747
[TBL] [Abstract][Full Text] [Related]
17. Assessment of drug interactions in hepatobiliary transport using rhodamine 123 in sandwich-cultured rat hepatocytes.
Annaert PP; Brouwer KL
Drug Metab Dispos; 2005 Mar; 33(3):388-94. PubMed ID: 15608134
[TBL] [Abstract][Full Text] [Related]
18. Culture period-dependent changes in the uptake of transporter substrates in sandwich-cultured rat and human hepatocytes.
Kotani N; Maeda K; Watanabe T; Hiramatsu M; Gong LK; Bi YA; Takezawa T; Kusuhara H; Sugiyama Y
Drug Metab Dispos; 2011 Sep; 39(9):1503-10. PubMed ID: 21673128
[TBL] [Abstract][Full Text] [Related]
19. Use of primary rat hepatocytes in the gel entrapment culture to predict in vivo biliary excretion.
Yin J; Meng Q
Xenobiotica; 2012 May; 42(5):417-28. PubMed ID: 22106963
[TBL] [Abstract][Full Text] [Related]
20. The hepatobiliary disposition of timosaponin b2 is highly dependent on influx/efflux transporters but not metabolism.
Sheng J; Tian X; Xu G; Wu Z; Chen C; Wang L; Pan L; Huang C; Pan G
Drug Metab Dispos; 2015 Jan; 43(1):63-72. PubMed ID: 25336752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
